https://onlinelibrary.wiley.com/doi/10.1111/resp.14767

⭐ HIGHLY CITED: Sustained remission induced by 2 years of treatment with #benralizumab in patients with severe #eosinophilic #asthma and nasal #polyposis
onlinelibrary.wiley.com/doi/10.1111/...

Respiratory Weekly News – June 13th 2025 Lung & Respiratory Breakthroughs: RSV Protection, STAT6 Alternatives, and Full CFTR Correction 🫁💊 This week on Lung and Respiratory Health […] The post Respiratory Weekly News – June 13th 2025 appeared first on LucidQuest Ventures.

FYI: LucidQuest Views >>> Respiratory Weekly News – June 13th 2025 #News #asthmatreatment #Benralizumab #CRResearch Comment below!

Respiratory Weekly News – June 13th 2025 Lung & Respiratory Breakthroughs: RSV Protection, STAT6 Alternatives, and Full CFTR Correction 🫁💊 This week on Lung and Respiratory Health […] The post Respiratory Weekly News – June 13th 2025 appeared first on LucidQuest Ventures.

ICYMI: LucidQuest Views >>> Respiratory Weekly News – June 13th 2025 #News #asthmatreatment #Benralizumab #CRResearch Comment below!

Respiratory Weekly News – June 13th 2025 Lung & Respiratory Breakthroughs: RSV Protection, STAT6 Alternatives, and Full CFTR Correction 🫁💊 This week on Lung and Respiratory Health […] The post Respiratory Weekly News – June 13th 2025 appeared first on LucidQuest Ventures.

LucidQuest Views >>> Respiratory Weekly News – June 13th 2025 #News #asthmatreatment #Benralizumab #CRResearch Comment below!

Out of Breath, out of Options: #Benralizumab as a Last Hope in ICU-Treated Near-Fatal #Eosinophilic #Asthma: A Case Series

Sixty seconds on . . . asthma injections Research published in the journal Lancet Respiratory Medicine found that an injection of a monoclonal antibody called benralizumab significantly reduced asthma attacks and chronic obstructive pulmonar...

Some media outlets seemed to oveplay this new asthma treatment. The phase 2 trial was very small. Is it too soon to call the monoclonal antibody called #benralizumab a "gamechanger"? Get the low down in 60 seconds www.bmj.com/content/387/...

First new asthma treatment in 50 years offers hope for millions The study demonstrated that asthma treatment is safe, with no significant side effects compared to past studies of the drug.

First new asthma treatment in 50 years offers hope for millions: The study demonstrated that asthma treatment is safe, with no significant side effects compared to past studies of the drug.

#AsthmaTreatment #Benralizumab #COPDTreatment #BiologicTherapy #PatientCare #EarthDotCom #EarthSnap #Earth

Επαναστατική #θεραπεία για το #άσθμα

Μετά από 50 χρόνια, μία νέα θεραπεία έρχεται για το άσθμα.

Το #φάρμακο #benralizumab στοχεύει ειδικά τα λευκά αιμοσφαίρια που προκαλούν φλεγμονές στους πνεύμονες αποδείχθηκε εξαιρετικά αποτελεσματικό ξεπερνώντας κατά πολύ τις υπάρχουσες θεραπείες με #στεροειδή

Treatment with the #benralizumab injection took longer to fail, meaning fewer episodes to see a doctor or go to hospital. There was also an improvement in the quality of life for people with asthma and COPD. 3/

#Benralizumab is a monoclonal antibody which targets eosinophils to reduce lung inflammation. The new trial has found a single dose can be more effective when injected at the point of exacerbation compared to steroid tablets. 2/

#Asthma #COPD #Benralizumab #UK #NewUseTrial

Doctors hail first breakthrough in asthma and COPD treatment in 50 years
Results of trial of benralizumab injection could be ‘gamechanger’ for millions of people around the world
www.theguardian.com/society/2024...

Great news on existing med. New use.

#ACR24 #YearInReview MANDARA Trial Benralizumab (IL-5Ri) vs Mepolizumab (IL5i) noninferiority study lead to 2024 FDA approval for benralizumab in #EGPA. Secondary outcomes: eosinophils fell more dramatically and more pts able to get off of GCs with #Benralizumab.